USPH Stock Forecast & Price Target

US Physical Therapy is facing some headwinds from a loss of patient visits, particularly in higher rate markets like New York, which may have resulted in lost revenue for the quarter. However, the company has seen solid growth in both its traditional Medicare business and its commercial pricing. Despite a slight increase in operating costs, USPH has demonstrated consistent profitability and continues to pursue growth opportunities, such as its recent acquisition and strategic partnerships. Looking towards the future, USPH is expected to see strong adjusted EBITDA and free cash flow in 2026, with potential for further growth through various operational improvements and partnerships.

US Physical Therapy is facing a negative outlook due to potentially declining profitability, as their adjusted EPS is expected to underperform the consensus estimate and adjusted EBITDA is the preferred metric for assessing operational performance. Additionally, the company's limited guidance only includes adjusted EBITDA, raising concerns about their financial performance. Furthermore, as the company's primary revenue comes from physical therapy services, any decline in demand for these services could further impact their profitability.